Multi-Type Interdependent Feature Analysis Based on Hybrid Neural Networks for Computer-Aided Diagnosis of Epidermal Growth Factor Receptor Mutations
暂无分享,去创建一个
Lingyun Jiang | Jian Chen | Kai Qiao | Bin Yan | Ruoxi Qin | Dapeng Shi | Jinjin Hai | Xilong Pei | Zhenzhen Wang | D. Shi | Jian Chen | Kai Qiao | B. Yan | Zhenzhen Wang | Ruoxi Qin | Jinjin Hai | Lingyun Jiang | Xilong Pei
[1] Renato Martins,et al. Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.
[2] Alona Muzikansky,et al. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Chun-Ming Tsai,et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Geraint Rees,et al. Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.
[5] D.M. Mount,et al. An Efficient k-Means Clustering Algorithm: Analysis and Implementation , 2002, IEEE Trans. Pattern Anal. Mach. Intell..
[6] Masahiro Endo,et al. The Impact of Clinical Outcomes According to EGFR Mutation Status in Patients with Locally Advanced Lung Adenocarcinoma Who Recieved Concurrent Chemoradiotherapy , 2014, American journal of clinical oncology.
[7] Ronald M. Summers,et al. Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning , 2016, IEEE Transactions on Medical Imaging.
[8] X. Chen,et al. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations , 2015, European Radiology.
[9] Liang Chen,et al. Attention-Gated Networks for Improving Ultrasound Scan Plane Detection , 2018, MICCAI 2018.
[10] Tianhong Li,et al. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Xiuying Wang,et al. Learning Deep Spatial Lung Features by 3D Convolutional Neural Network for Early Cancer Detection , 2017, 2017 International Conference on Digital Image Computing: Techniques and Applications (DICTA).
[12] Xiwen Sun,et al. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma. , 2019, European journal of radiology.
[13] Jun Ma,et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. , 2011, The Lancet. Oncology.
[14] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[15] John Quackenbush,et al. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.
[16] Kilian Q. Weinberger,et al. Densely Connected Convolutional Networks , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[17] Raunak Dey,et al. Diagnostic classification of lung nodules using 3D neural networks , 2018, 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018).
[18] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[19] David Cella,et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. , 2003, JAMA.
[20] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[21] Raghuram Srinivasan,et al. Convolutional neural networks for lung cancer screening in computed tomography (CT) scans , 2016, 2016 2nd International Conference on Contemporary Computing and Informatics (IC3I).
[22] H. Hricak,et al. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. , 2013, Radiology.
[23] Fabio A. González,et al. Gated Multimodal Units for Information Fusion , 2017, ICLR.
[24] Andriy Fedorov,et al. Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.
[25] William Pao,et al. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma , 2011, European Respiratory Journal.
[26] Masaki Hara,et al. Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] Rufaidah Rushdi,et al. Common Fallacies of Probability in Medical Context: A Simple Mathematical Exposition , 2018 .
[28] Ying Liu,et al. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma. , 2016, Radiology.
[29] Haibo Zhang,et al. Interstitial lung disease classification using improved DenseNet , 2018, Multimedia Tools and Applications.
[30] H. Aerts. Semantics Features : Phenotype Quantification by a Radiologist ’ s Expert Eye , 2016 .
[31] Junzhou Huang,et al. Efficient Lung Cancer Cell Detection with Deep Convolution Neural Network , 2015, Patch-MI@MICCAI.
[32] Wenqing Sun,et al. Computer aided lung cancer diagnosis with deep learning algorithms , 2016, SPIE Medical Imaging.
[33] Jürgen Schmidhuber,et al. Long Short-Term Memory , 1997, Neural Computation.
[34] Nicolas Girard,et al. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma , 2012, European Respiratory Journal.
[35] C F Loughran,et al. Seeding of tumour cells following breast biopsy: a literature review. , 2011, The British journal of radiology.
[36] Y. Liu,et al. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas. , 2016, Clinical lung cancer.